Takeda Pharmaceutical Company Limited
Research Takeda Pharmaceutical Company Limited (4502) on Bullrun: market cap JPY 9.26T, dividend yield 3.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4502
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyJPY
- Market capJPY 9.26T
- Dividend yield3.5%
- Financial periodQ1 2026
- RevenueJPY 1.09T
- Net income-JPY 368.47B
- Free cash flowJPY 10.14B
- Gross margin62.9%
Valuation Snapshot
latest market cap is JPY 9.26T; dividend yield is 3.5%.
Peer valuation comparison
Latest dividend yield is 3.45% versus a Healthcare sector median of 2.11% (63.5% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | JPY 4.46T | JPY 112.93B | JPY 746.07B | 65.3% | n/a | JPY 654.94B | JPY 4.85T | JPY 7.64T |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-28 | JPY 9.26T | n/a | 3.5% | 204 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 204 JPY, yield 3.5%.
About Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Takeda Pharmaceutical Company Limited's market cap?
Takeda Pharmaceutical Company Limited's market capitalization is JPY 9.26T.
Does Takeda Pharmaceutical Company Limited pay a dividend?
Takeda Pharmaceutical Company Limited has a dividend yield of 3.5%.
What does Takeda Pharmaceutical Company Limited do?
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience.